TY - JOUR
T1 - Bioactive Compounds as Potential Agents for Sexually Transmitted Diseases Management
T2 - A Review to Explore Molecular Mechanisms of Action
AU - Sharifi-Rad, Javad
AU - Quispe, Cristina
AU - Rahavian, Amirhossein
AU - Pereira Carneiro, Joara Nályda
AU - Rocha, Janaína Esmeraldo
AU - Alves Borges Leal, Antônio Linkoln
AU - Bezerra Morais Braga, Maria Flaviana
AU - Melo Coutinho, Henrique Douglas
AU - Ansari Djafari, Anahita
AU - Alarcón-Zapata, Pedro
AU - Martorell, Miquel
AU - Antika, Gizem
AU - Tumer, Tugba Boyunegmez
AU - Cruz-Martins, Natália
AU - Helon, Paweł
AU - Paprocka, Paulina
AU - Koch, Wojciech
AU - Docea, Anca Oana
AU - Calina, Daniela
N1 - Publisher Copyright:
© Copyright © 2021 Sharifi-Rad, Quispe, Rahavian, Pereira Carneiro, Rocha, Alves Borges Leal, Bezerra Morais Braga, Melo Coutinho, Ansari Djafari, Alarcón-Zapata, Martorell, Antika, Tumer, Cruz-Martins, Helon, Paprocka, Koch, Docea and Calina.
PY - 2021/8/24
Y1 - 2021/8/24
N2 - Sexually transmitted diseases (STDs) are produced by pathogens like bacteria, fungi, parasites, and viruses, and may generate severe health problems such as cancer, ulcers, and even problems in the newborn. This narrative review aims to present updated information about the use of natural bioactive compounds for the prevention and treatment of sexually transmitted infections. A search of the literature was performed using databases and search engines such as PubMed, Scopus, Google Scholar and Science Direct. From the pharmacotherapeutic management point of view, any strategies for prevention should contain medical approaches. The bioactive compounds obtained from natural products have shown biological effects against different microorganisms for the treatment of these diseases. The main results showed antimicrobial, antiprotozoal, antifungal and antiviral effects such as HIV. Also, the molecular mechanisms, signalling pathways and action targets of natural compounds were highlighted, thus justifying bacterial and antifungal inhibition, apoptosis or reduction of viral replication. From the data of our study, we can conclude that natural compounds may be a significant source for adjuvant drugs / complementary therapies in the treatment of STDs. With all these benefits, the future must conduct extensive clinical trials and the development of pharmaceutical nanotechnologies for a greater therapeutic effect.
AB - Sexually transmitted diseases (STDs) are produced by pathogens like bacteria, fungi, parasites, and viruses, and may generate severe health problems such as cancer, ulcers, and even problems in the newborn. This narrative review aims to present updated information about the use of natural bioactive compounds for the prevention and treatment of sexually transmitted infections. A search of the literature was performed using databases and search engines such as PubMed, Scopus, Google Scholar and Science Direct. From the pharmacotherapeutic management point of view, any strategies for prevention should contain medical approaches. The bioactive compounds obtained from natural products have shown biological effects against different microorganisms for the treatment of these diseases. The main results showed antimicrobial, antiprotozoal, antifungal and antiviral effects such as HIV. Also, the molecular mechanisms, signalling pathways and action targets of natural compounds were highlighted, thus justifying bacterial and antifungal inhibition, apoptosis or reduction of viral replication. From the data of our study, we can conclude that natural compounds may be a significant source for adjuvant drugs / complementary therapies in the treatment of STDs. With all these benefits, the future must conduct extensive clinical trials and the development of pharmaceutical nanotechnologies for a greater therapeutic effect.
KW - clinical studies
KW - mechanisms
KW - molecular targets
KW - natural compounds
KW - pathogens
KW - pharmacological effects
KW - sexually transmitted diseases (STDs)
UR - https://www.scopus.com/pages/publications/85114431688
U2 - 10.3389/fphar.2021.674682
DO - 10.3389/fphar.2021.674682
M3 - Review article
AN - SCOPUS:85114431688
SN - 1663-9812
VL - 12
JO - Frontiers in Pharmacology
JF - Frontiers in Pharmacology
M1 - 674682
ER -